Published in Adv Healthc Mater on April 15, 2013
pH-responsive drug delivery system based on hollow silicon dioxide micropillars coated with polyelectrolyte multilayers. Nanoscale Res Lett (2014) 0.82
Cefazolin-loaded mesoporous silicon microparticles show sustained bactericidal effect against Staphylococcus aureus. J Tissue Eng (2014) 0.79
In vitro cytotoxicity of SiO2 or ZnO nanoparticles with different sizes and surface charges on U373MG human glioblastoma cells. Int J Nanomedicine (2014) 0.78
Chemical patterning on preformed porous silicon photonic crystals: towards multiplex detection of protease activity at precise positions†Electronic supplementary information (ESI) available: SEM images, XPS result and more optical reflectivity data. See DOI: 10.1039/c4tb00281dClick here for additional data file. J Mater Chem B Mater Biol Med (2014) 0.77
Impedance characterization, degradation, and in vitro biocompatibility for platinum electrodes on BioMEMS. Biomed Microdevices (2015) 0.76
Composite nanoparticles for gene delivery. Adv Genet (2014) 0.75
A brief review of recent developments in the designs that prevent bio-fouling on silicon and silicon-based materials. Chem Cent J (2017) 0.75
Sustained Administration of Hormones Exploiting Nanoconfined Diffusion through Nanochannel Membranes. Materials (Basel) (2015) 0.75
Nanoscale Semiconductor Devices as New Biomaterials. Biomater Sci (2014) 0.75
The hallmarks of cancer. Cell (2000) 113.05
Towards a proteome-scale map of the human protein-protein interaction network. Nature (2005) 24.76
Tissue engineering. Science (1993) 19.65
A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem (2004) 19.20
Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science (1996) 16.69
Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer (2005) 13.49
Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov (2005) 10.97
Ion-beam sculpting at nanometre length scales. Nature (2001) 8.81
The dawning era of polymer therapeutics. Nat Rev Drug Discov (2003) 7.86
How useful is SBF in predicting in vivo bone bioactivity? Biomaterials (2006) 7.80
Heparin-protein interactions. Angew Chem Int Ed Engl (2002) 7.27
The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A (2008) 7.06
Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W. J Biomed Mater Res (1990) 7.05
The case for early detection. Nat Rev Cancer (2003) 6.96
Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J (2004) 6.90
Impact of nanotechnology on drug delivery. ACS Nano (2009) 6.87
Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol (2007) 6.85
Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov (2003) 6.66
Role of target geometry in phagocytosis. Proc Natl Acad Sci U S A (2006) 6.62
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul (2001) 6.59
The anti-angiogenic basis of metronomic chemotherapy. Nat Rev Cancer (2004) 6.32
Fabrication of solid-state nanopores with single-nanometre precision. Nat Mater (2003) 6.31
Scaffolds in tissue engineering bone and cartilage. Biomaterials (2000) 6.11
Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol (2000) 5.94
Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer (2006) 5.75
High-resolution conformation of gramicidin A in a lipid bilayer by solid-state NMR. Science (1993) 5.33
Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev (2004) 5.31
Designing dendrimers for biological applications. Nat Biotechnol (2005) 4.92
Current two-dimensional electrophoresis technology for proteomics. Proteomics (2004) 4.87
Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res (2005) 4.71
Metal-assisted chemical etching of silicon: a review. Adv Mater (2011) 4.44
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials (2000) 4.42
A laser ablation method for the synthesis of crystalline semiconductor nanowires Science (1998) 4.34
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels. Ann Oncol (2002) 4.32
Mining the plasma proteome for cancer biomarkers. Nature (2008) 4.10
The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng (2001) 3.91
Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol (2008) 3.78
Proteomic applications for the early detection of cancer. Nat Rev Cancer (2003) 3.61
The emerging nanomedicine landscape. Nat Biotechnol (2006) 3.60
New methods of drug delivery. Science (1990) 3.56
First-in-human testing of a wirelessly controlled drug delivery microchip. Sci Transl Med (2012) 3.56
Insulin-like growth factor II receptor as a multifunctional binding protein. Nature (1987) 3.52
Porous silicon in drug delivery devices and materials. Adv Drug Deliv Rev (2008) 3.43
Bone tissue engineering: state of the art and future trends. Macromol Biosci (2004) 3.30
Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice. J Clin Invest (2000) 3.26
Biomolecular screening with encoded porous-silicon photonic crystals. Nat Mater (2002) 3.13
Intravascular delivery of particulate systems: does geometry really matter? Pharm Res (2008) 3.13
Bone graft materials. An overview of the basic science. Clin Orthop Relat Res (2000) 3.10
Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release (2009) 3.08
Metronomic chemotherapy: new rationale for new directions. Nat Rev Clin Oncol (2010) 3.02
Clinical proteomics: written in blood. Nature (2003) 2.81
Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Res (2010) 2.80
Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials (2004) 2.80
Plasma sprayed coatings of hydroxylapatite. J Biomed Mater Res (1987) 2.78
Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet (2002) 2.76
Nanomedicine--challenge and perspectives. Angew Chem Int Ed Engl (2009) 2.74
Vertical silicon nanowires as a universal platform for delivering biomolecules into living cells. Proc Natl Acad Sci U S A (2010) 2.74
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm (2008) 2.71
Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol Ther (2008) 2.69
Mesoporous silicon in drug delivery applications. J Pharm Sci (2008) 2.68
Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther (2002) 2.63
Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet (1999) 2.62
Stem cells in tissue engineering. Nature (2001) 2.62
Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res (1990) 2.61
Seven challenges for nanomedicine. Nat Nanotechnol (2008) 2.59
Biomaterial developments for bone tissue engineering. Biomaterials (2000) 2.48
A controlled-release microchip. Nature (1999) 2.39
Biomaterials in tissue engineering. Biotechnology (N Y) (1995) 2.29
Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun (2000) 2.28
Biocompatibility and biofouling of MEMS drug delivery devices. Biomaterials (2003) 2.27
Nanotechnology and cancer. Annu Rev Med (2008) 2.25
Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics (2002) 2.24
Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res (2001) 2.24
Bioactive glass in tissue engineering. Acta Biomater (2011) 2.23
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials (2008) 2.21
Electrostatic control of ions and molecules in nanofluidic transistors. Nano Lett (2005) 2.21
Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast. Nat Nanotechnol (2010) 2.17
Intracellular recording of action potentials by nanopillar electroporation. Nat Nanotechnol (2012) 2.06
Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow. Proc Natl Acad Sci U S A (1998) 2.06
Vertical nanowire electrode arrays as a scalable platform for intracellular interfacing to neuronal circuits. Nat Nanotechnol (2012) 2.05
The contribution of bone to whole-organism physiology. Nature (2012) 2.03
Single-file diffusion of protein drugs through cylindrical nanochannels. ACS Nano (2010) 2.03
In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes (2004) 2.01
Electrically conductive and optically active porous silicon nanowires. Nano Lett (2009) 2.00
Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. J Control Release (2005) 1.97
Size of IgG-opsonized particles determines macrophage response during internalization. Exp Cell Res (1998) 1.91
Functionalized micellar systems for cancer targeted drug delivery. Pharm Res (2007) 1.90
Frontiers in cancer nanomedicine: directing mass transport through biological barriers. Trends Biotechnol (2010) 1.90
Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med (1979) 1.88
Principles and applications of nanofluidic transport. Nat Nanotechnol (2009) 1.88
Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. Cancer Res (1992) 1.81
The blood peptidome: a higher dimension of information content for cancer biomarker discovery. Nat Rev Cancer (2006) 1.79
Control of thickness and orientation of solution-grown silicon nanowires Science (2000) 1.78
Design maps for nanoparticles targeting the diseased microvasculature. Biomaterials (2007) 1.72
Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. J Control Release (2011) 1.72
Tailored porous silicon microparticles: fabrication and properties. Chemphyschem (2010) 1.71
Proteins and cells on PEG immobilized silicon surfaces. Biomaterials (1998) 1.69
Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation In vitro: implications and applications for bone tissue engineering. Calcif Tissue Int (2000) 1.68
The receptor-mediated endocytosis of nonspherical particles. Biophys J (2008) 1.68
The role of complement in biomaterial-induced inflammation. Mol Immunol (2006) 1.67
Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol (2008) 3.78
Intravascular delivery of particulate systems: does geometry really matter? Pharm Res (2008) 3.13
Clinical proteomics: written in blood. Nature (2003) 2.81
Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Res (2010) 2.80
Nanomedicine--challenge and perspectives. Angew Chem Int Ed Engl (2009) 2.74
Nanotechnologies for biomolecular detection and medical diagnostics. Curr Opin Chem Biol (2006) 2.74
Seven challenges for nanomedicine. Nat Nanotechnol (2008) 2.59
Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast. Nat Nanotechnol (2010) 2.17
Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol (2012) 1.85
Design maps for nanoparticles targeting the diseased microvasculature. Biomaterials (2007) 1.72
Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. J Control Release (2011) 1.72
Tailored porous silicon microparticles: fabrication and properties. Chemphyschem (2010) 1.71
Asthma symptoms in Hispanic children and daily ambient exposures to toxic and criteria air pollutants. Environ Health Perspect (2003) 1.64
Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows. Nanotechnology (2009) 1.63
The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. Biomaterials (2009) 1.63
Phosphatized polar lobe-forming embryos from the Precambrian of southwest China. Science (2006) 1.61
What does physics have to do with cancer? Nat Rev Cancer (2011) 1.59
Morphologic instability and cancer invasion. Clin Cancer Res (2005) 1.55
Nanogeometry: beyond drug delivery. Nat Nanotechnol (2008) 1.54
Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis. Circ Res (2013) 1.54
Prediction of drug response in breast cancer using integrative experimental/computational modeling. Cancer Res (2009) 1.53
Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. PLoS One (2010) 1.49
Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulation. J Math Biol (2008) 1.48
Osmotic pressure beyond concentration restrictions. J Phys Chem B (2007) 1.46
Sensitive and specific ELISA coated by TpN15-TpN17-TpN47 fusion protein for detection of antibodies to Treponema pallidum. Clin Chem Lab Med (2009) 1.46
Biotechnology apprenticeship for secondary-level students: teaching advanced cell culture techniques for research. Cell Biol Educ (2002) 1.45
Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics. Acc Chem Res (2011) 1.45
Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells. Cell Biochem Funct (2012) 1.44
T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc Natl Acad Sci U S A (2003) 1.37
Antibiological barrier nanovector technology for cancer applications. Expert Opin Drug Deliv (2007) 1.36
Integrated intravital microscopy and mathematical modeling to optimize nanotherapeutics delivery to tumors. AIP Adv (2012) 1.35
Mitotic trafficking of silicon microparticles. Nanoscale (2009) 1.35
Discoidal Porous Silicon Particles: Fabrication and Biodistribution in Breast Cancer Bearing Mice. Adv Funct Mater (2012) 1.35
A physical sciences network characterization of non-tumorigenic and metastatic cells. Sci Rep (2013) 1.33
Cellular association and assembly of a multistage delivery system. Small (2010) 1.32
Biodegradable porous silicon barcode nanowires with defined geometry. Adv Funct Mater (2010) 1.31
Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation. J Biomed Mater Res A (2010) 1.31
Mathematical modeling of cancer progression and response to chemotherapy. Expert Rev Anticancer Ther (2006) 1.30
Multiparameter computational modeling of tumor invasion. Cancer Res (2009) 1.28
Enabling individualized therapy through nanotechnology. Pharmacol Res (2010) 1.28
Nanomedicine in cancer therapy: innovative trends and prospects. Cancer Sci (2011) 1.27
Transport properties of pancreatic cancer describe gemcitabine delivery and response. J Clin Invest (2014) 1.26
The preferential targeting of the diseased microvasculature by disk-like particles. Biomaterials (2012) 1.25
Interstitial stress and fluid pressure within a growing tumor. Ann Biomed Eng (2003) 1.25
Multi-stage delivery nano-particle systems for therapeutic applications. Biochim Biophys Acta (2010) 1.23
NDRG2: a Myc-repressed gene involved in cancer and cell stress. Acta Biochim Biophys Sin (Shanghai) (2008) 1.23
Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases. Trends Pharmacol Sci (2010) 1.22
Candidate microRNA biomarkers in human gastric cancer: a systematic review and validation study. PLoS One (2013) 1.22
MMP-Cliffs: systematic identification of activity cliffs on the basis of matched molecular pairs. J Chem Inf Model (2012) 1.22
Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery. Clin Cancer Res (2013) 1.21
Logic-embedded vectors for intracellular partitioning, endosomal escape, and exocytosis of nanoparticles. Small (2010) 1.19
Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting. PLoS One (2010) 1.19
Cooperative, nanoparticle-enabled thermal therapy of breast cancer. Adv Healthc Mater (2011) 1.16
Quantitative mechanics of endothelial phagocytosis of silicon microparticles. Cytometry A (2009) 1.16